Compass Pathways 递交 COMP360 新药申请;Kudzu 补充剂减少酗酒
AI Suicide Lawsuit; School Phone Ban Results; Kudzu for Binge Drinking?
Compass Pathways 已向 FDA 递交 COMP360(合成裸麦素)用于治疗难治性抑郁症的新药申请。一项随机对照试验显示,服用 Kudzu 补充剂的酒精依赖患者显著减少了酗酒天数。
— News and commentary from the psychiatry world
November 11, 2026 • 2 min read
Google's artificial intelligence (AI) chatbot Gemini helped a 13-year-old girl prepare a suicide plan, according to a lawsuit in California that alleges the company released the chatbot knowing it could be dangerous. (The Hill)
An employee of the Substance Abuse and Mental Health Services Administration (SAMHSA) died by suicide last month. (Government Executive)
In a systematic review and network meta-analysis, escitalopram, duloxetine, and agomelatine demonstrated higher sustained response rates for major depressive disorder compared with fluoxetine, while bupropion and reboxetine showed lower sustained response rates compared with four other antidepressants. (Lancet Psychiatry)
Compass Pathways submitted a new drug application to the FDA for COMP360, its synthetic psilocybin formulation for treatment-resistant depression.
Iceland's mobile phone ban in 70 schools was not associated with meaningful changes in adolescent mental health or related social and behavioral outcomes, a cross-sectional study showed. (JAMA Network Open)
Cannabis was implicated in the majority of substance-related emergency department admissions among adolescents and young adults, according to a study in the American Journal of Psychiatry.
The American Society of Addiction Medicine released its first clinical guidance on managing intoxication and withdrawal from veterinary sedative medetomidine.
Taking the herbal supplement kudzu prior to anticipated binge drinking was associated with a significant reduction in binge days compared with placebo in a randomized trial of adults with alcohol use disorder. (American Journal of Psychiatry)
Following an industry lobbying campaign, the Trump administration will allow products with a kratom-derived opioid to stay on the market below specified potency thresholds. (New York Times)
The Department of Justice announced it charged a Virginia mental health provider in a $49 million crisis services fraud scheme targeting the state's Medicaid program.
来源:MedPage Today · medpagetoday.com